GO:0002251 organ or tissue specific immune response: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002251 describes an immune response that takes place in a specific organ or tissue, such as the liver, brain, mucosa, or nervous system.
• Structural cells (e.g., epithelial, endothelial, stromal) are key regulators of organ-specific immune responses, not passive bystanders.
• Tissue-specific immune responses involve resident immune cells, tertiary lymphoid structures, and local danger signals such as DAMPs [3,4].
• The composition and function of immune cells differ by tissue and by sex, affecting disease susceptibility and outcomes.
• Microbiota and environmental factors shape organ-specific immune function, as shown in spleen and intestinal models [5,6].
• Studying GO:0002251 requires tissue-resolved methods such as single-cell RNA-seq, spatial transcriptomics, and organ-specific knockout models [2,6].
Description
The Gene Ontology term GO:0002251, organ or tissue specific immune response, defines an immune response that occurs within a particular organ or tissue, such as the liver, brain, mucosa, or nervous system. This concept is essential because immune reactions are not uniform throughout the body; each tissue has a unique microenvironment that shapes how immune cells behave and how pathogens or damage are handled. Researchers increasingly recognize that structural cells of an organ actively regulate local immunity, influencing both protective and pathological outcomes. Understanding GO:0002251 helps explain why the same immune stimulus can produce different effects in different tissues, and why therapies targeting immunity must consider tissue context [1,2]. This article summarizes the definition, mechanisms, key genes, disease links, and research methods relevant to organ or tissue specific immune responses, based on published literature.
organ or tissue specific immune response At A Glance
| GO ID | GO:0002251 |
|---|---|
| GO term | organ or tissue specific immune response |
| Ontology | biological_process |
| Synonym | immune response in organ or tissue |
| Definition | An immune response taking place in an organ or tissues such as the liver, brain, mucosa, or nervous system tissues. |
| Major function | Local immune defense and regulation within specific organs or tissues, involving resident and recruited immune cells and structural cells. |
| Related processes | Tertiary lymphoid structure formation, tissue-resident memory T cell responses, and organ-specific inflammation. |
| Key cell types | Tissue-resident macrophages, dendritic cells, mast cells, innate lymphoid cells, and structural cells (epithelial, endothelial, stromal). |
| Research relevance | Understanding organ-specific immunity is crucial for developing targeted therapies for infections, autoimmunity, and cancer [1,2]. |
What Is GO:0002251?
In simple terms, GO:0002251 refers to any immune response that takes place in a specific organ or tissue rather than systemically. The official definition is: An immune response taking place in an organ or tissues such as the liver, brain, mucosa, or nervous system tissues. This includes local innate and adaptive immune reactions, such as those mediated by tissue-resident macrophages, mast cells, and lymphocytes, as well as interactions with structural cells like epithelial and endothelial cells. The term also encompasses the formation of tertiary lymphoid structures in non-lymphoid organs during chronic inflammation. Because the tissue microenvironment influences immune cell recruitment, activation, and resolution, GO:0002251 is a critical concept for understanding organ-specific pathology and immunity [1,2].
Why Is organ or tissue specific immune response Important in Cell Biology?
Organ or tissue specific immune responses are fundamental to health and disease because they determine how each organ handles infection, injury, and malignant transformation. For example, the liver's immune microenvironment can promote tolerance or trigger sterile inflammation, while the brain's immune response is shaped by microglia and the blood-brain barrier [2,4]. Dysregulation of these local responses contributes to autoimmune diseases, chronic inflammation, and cancer progression [3,8]. Moreover, tissue-specific differences in immune cell composition and function, including sex-based differences, can affect disease susceptibility and treatment outcomes. Therefore, studying GO:0002251 is essential for understanding disease mechanisms and for designing organ-targeted immunotherapies [2,3].
• Explains why immune responses differ between organs, such as liver versus brain versus mucosa.
• Highlights the role of structural cells (epithelial, endothelial, stromal) as active regulators of local immunity.
• Underlies the formation of tertiary lymphoid structures in chronic inflammation and autoimmunity [3,8].
• Contributes to sterile inflammatory liver injury through DAMPs and neutrophil extracellular traps.
• Involves intestinal tuft cells that detect succinate and trigger type 2 innate immune circuits.
• Microbiota shape spleen structure and immune function, affecting systemic and local immunity.
• Mycotoxins like zearalenone can modulate immune responses, with implications for organ-specific effects.
• Sex differences in immune cell composition and function are tissue-specific and affect disease outcomes.
• Relevant for cancer immunotherapy, as tumor microenvironments are organ-specific.
• Guides development of tissue-targeted vaccines and immunomodulatory drugs [2,3].
What Happens During organ or tissue specific immune response?
Initiation by local danger signals
In simple terms: When a tissue is damaged or infected, it releases signals that alert the immune system.
Organ-specific immune responses often begin with the release of damage-associated molecular patterns (DAMPs) from stressed or dying cells. In the liver, DAMPs activate neutrophils to form extracellular traps, exacerbating sterile inflammatory liver injury. Similarly, intestinal tuft cells detect succinate and initiate a type 2 innate immune circuit, demonstrating how local metabolites can trigger tissue-specific immunity. These initial signals recruit and activate resident immune cells, setting the stage for a localized response.
Activation of tissue-resident immune cells
In simple terms: Immune cells already living in the tissue wake up and start responding.
Tissues contain resident immune cells such as macrophages, dendritic cells, mast cells, and innate lymphoid cells. These cells express pattern recognition receptors and respond to local cues. Structural cells, including epithelial and endothelial cells, actively regulate these responses by presenting antigens and secreting cytokines. For example, in the spleen, microbiota-mediated signals shape the structure and function of immune cells, as revealed by single-cell RNA-seq and spatial transcriptomics. The composition of resident immune cells can vary by tissue and by sex, influencing the nature of the response.
Recruitment of circulating immune cells
In simple terms: More immune cells are called in from the blood to help.
If the local response is insufficient, chemokines and adhesion molecules produced by tissue cells recruit circulating leukocytes. This process is organ-specific because endothelial cells in different tissues express distinct adhesion molecules and chemokines. In chronic inflammation, this recruitment can lead to the formation of tertiary lymphoid structures (TLSs), which are organized aggregates of immune cells in non-lymphoid organs. Stromal cells within TLSs act as architects, supporting lymphocyte organization and autoimmunity.
Effector functions and resolution
In simple terms: The immune cells do their job and then the response is shut down.
Once recruited, immune cells carry out effector functions such as phagocytosis, cytokine production, and cytotoxicity. In the liver, neutrophil extracellular traps can exacerbate injury, but resolution mechanisms exist to limit damage. In the intestine, type 2 innate immune circuits promote mucus production and worm expulsion. Resolution involves anti-inflammatory cytokines, apoptosis of immune cells, and tissue repair. Dysregulation of these steps can lead to chronic inflammation or autoimmunity [3,8].
Formation of tertiary lymphoid structures
In simple terms: Long-lasting inflammation can cause immune cells to form organized clusters in the tissue.
Tertiary lymphoid structures (TLSs) are ectopic lymphoid organs that develop in non-lymphoid tissues during chronic inflammation, autoimmunity, and cancer. They contain T cell zones, B cell follicles, and high endothelial venules, and are supported by stromal cells such as fibroblastic reticular cells. TLSs can be beneficial by promoting local immune responses against tumors, but they can also perpetuate autoimmunity [3,8]. Their formation is a hallmark of organ-specific immune responses in diseases like rheumatoid arthritis and Sjögren's syndrome.
Key Genes Involved in GO:0002251 organ or tissue specific immune response
The following genes and proteins are involved in organ or tissue specific immune responses, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ILC2 | Innate lymphoid cells type 2 | Produce type 2 cytokines in mucosal tissues |
| Tuft cell | Intestinal chemosensory cells | Detect succinate and trigger type 2 immunity |
| Neutrophil elastase | Enzyme released by neutrophils | Mediates NET formation in liver injury |
| PAD4 | Peptidylarginine deiminase 4 | Citrullinates histones for NET formation |
| CXCL12 | Chemokine | Recruits immune cells to tissues |
| CCL19 | Chemokine | Guides T cell and dendritic cell positioning in TLS |
| CCL21 | Chemokine | Organizes T cell zones in lymphoid structures |
| LTβR | Lymphotoxin beta receptor | Signaling for TLS formation |
| TNF | Tumor necrosis factor | Promotes inflammation and TLS development |
| IL-17 | Interleukin 17 | Drives tissue inflammation |
| IL-22 | Interleukin 22 | Promotes epithelial barrier function |
| MHC class II | Antigen presentation | Expressed by structural cells to regulate T cells |
| PD-L1 | Immune checkpoint | Regulates local immune suppression |
| Foxp3 | Regulatory T cell marker | Suppresses organ-specific autoimmunity |
| RORγt | Transcription factor | Required for ILC3 and Th17 cells |
| GATA3 | Transcription factor | Required for ILC2 and Th2 cells |
| STAT6 | Signal transducer | Mediates IL-4/IL-13 signaling in type 2 immunity |
| NLRP3 | Inflammasome sensor | Activates IL-1β in sterile inflammation |
How Is organ or tissue specific immune response Regulated?
Organ or tissue specific immune responses are regulated at multiple levels. Locally, structural cells such as epithelial and endothelial cells secrete cytokines and express adhesion molecules that control immune cell recruitment and activation. Chemokines like CXCL12, CCL19, and CCL21 organize immune cells into distinct zones, and their expression is regulated by lymphotoxin and TNF signaling. Microbiota-derived signals shape the development and function of immune cells in organs like the spleen and intestine [5,6]. Sex hormones also influence tissue-specific immune responses, as evidenced by sex differences in immune cell composition and function. Additionally, environmental factors such as mycotoxins can modulate immune responses, potentially affecting organ-specific immunity. These regulatory mechanisms ensure that immune responses are tailored to the needs of each tissue while preventing excessive damage.
organ or tissue specific immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PAD4 | Sterile inflammatory liver injury | PAD4 knockout mice with liver ischemia-reperfusion |
| ILC2 | Intestinal helminth infection and type 2 inflammation | ILC2-deficient mice or reporter mice |
| LTβR | Tertiary lymphoid structure formation in autoimmunity | LTβR knockout or conditional knockout mice |
| Foxp3 | Autoimmune diseases (e.g., IPEX) | Foxp3 knockout mice or human iPSC-derived Tregs |
| NLRP3 | Inflammasome-mediated liver injury | NLRP3 knockout mice |
Autoimmune diseases and tertiary lymphoid structures
Tertiary lymphoid structures (TLSs) are often found in target organs of autoimmune diseases such as rheumatoid arthritis, Sjögren's syndrome, and multiple sclerosis [3,8]. Stromal cells within TLSs promote the survival and activation of autoreactive B and T cells, leading to chronic inflammation and tissue damage. Targeting TLS formation or function is a promising therapeutic strategy for autoimmunity.
Sterile inflammatory liver injury
In the liver, damage-associated molecular patterns (DAMPs) activate neutrophils to release neutrophil extracellular traps (NETs), which exacerbate sterile inflammatory liver injury. This process involves PAD4-mediated histone citrullination and neutrophil elastase. Understanding this organ-specific immune response is critical for developing treatments for liver ischemia-reperfusion injury and other sterile inflammatory conditions.
Intestinal immunity and type 2 inflammation
Intestinal tuft cells detect succinate from the microbiota and trigger a type 2 innate immune circuit involving ILC2s and IL-25, leading to mucus production and worm expulsion. Dysregulation of this circuit can contribute to inflammatory bowel diseases or impaired defense against helminths. This exemplifies how organ-specific immune responses are shaped by local environmental cues.
Cancer and organ-specific tumor immunity
Tertiary lymphoid structures in tumors are associated with favorable prognosis in many cancers, as they promote local anti-tumor immune responses. However, tumors can also exploit organ-specific immune suppression mechanisms, such as PD-L1 expression, to evade immunity. Understanding the balance between protective and pathogenic organ-specific immunity is key for cancer immunotherapy.
From organ or tissue specific immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate organ-specific immune cell recruitment? | Tissue-specific knockout (e.g., Cre-lox) in mice |
| Does a point mutation in gene Y alter local immune signaling? | CRISPR point-mutation knock-in in cell lines or mice |
| How does a tagged protein localize in tissue-resident immune cells? | Knock-in of fluorescent or epitope tag |
| Does overexpression of gene Z drive tertiary lymphoid structure formation? | Transgenic overexpression in mice |
| What is the role of gene W in intestinal tuft cell immunity? | Intestinal organoids with CRISPR knockout |
| Can a drug modulate organ-specific immune response? | Human tissue explants or organ-on-chip |
How to Study the organ or tissue specific immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| scRNA-seq | Gene expression at single-cell level | Immune cell heterogeneity in tissues |
| Spatial transcriptomics | Gene expression with spatial context | Tissue architecture of immune responses |
| Multiplex immunofluorescence | Protein localization and co-expression | Visualizing TLS and immune cell interactions |
| Organoid culture | Functional responses in a tissue-like context | Intestinal tuft cell immunity |
| Conditional knockout mice | Gene function in specific tissues | Liver injury and NET formation |
| Proteomics | Protein abundance and modifications | Identifying signaling pathways in local immunity |
| Flow cytometry | Immune cell phenotyping and quantification | Characterizing tissue-resident immune cells |
| ATAC-seq | Chromatin accessibility | Regulatory elements in tissue-specific immune cells |
Single-cell and spatial transcriptomics
Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics allow researchers to map immune cell composition and gene expression within specific tissues. For example, scRNA-seq and Stereo-seq revealed how microbiota shape spleen structure and immune function. These methods are essential for understanding the heterogeneity of organ-specific immune responses [2,6].
Tissue-resolved proteomics and imaging
Proteomic analyses of sorted immune cells or laser-capture microdissected tissue regions can identify proteins involved in local immunity. Imaging techniques such as multiplex immunofluorescence and confocal microscopy visualize immune cell interactions with structural cells in situ [2,3]. These approaches help validate findings from transcriptomic studies.
Organoid and tissue explant models
Intestinal organoids and tissue explants preserve the local microenvironment and allow functional studies of organ-specific immune responses. For instance, intestinal tuft cells can be studied in organoids to dissect succinate detection and type 2 immune activation. Liver explants can model sterile inflammation and NET formation.
Genetic mouse models
Conditional knockout, knock-in, and transgenic mice are invaluable for studying gene function in organ-specific immunity. Cre-lox systems enable tissue-specific deletion of genes such as PAD4 or LTβR [4,8]. Reporter mice and fate-mapping models track immune cell dynamics in vivo.
How CRISPR Can Be Used to Study GO:0002251 organ or tissue specific immune response
Knockout
CRISPR knockout is used to delete genes in cell lines or animal models to study their role in organ-specific immune responses. For example, knocking out PAD4 in mice reduces NET formation and liver injury. Tissue-specific knockout using Cre-lox and CRISPR can reveal gene functions in particular organs.
Point Mutation
CRISPR point mutation (base editing or prime editing) introduces specific amino acid changes to study protein function. This is useful for dissecting signaling pathways, such as mutations in NLRP3 that affect inflammasome activation in liver inflammation. Point mutations can also model human disease variants in organ-specific immunity.
Knock-in
CRISPR knock-in allows insertion of tags (e.g., GFP, HA) or reporter genes into endogenous loci to track protein expression and localization in tissues. For instance, tagging ILC2-specific genes can help visualize their distribution in mucosal tissues. Knock-in of human disease alleles into mice can model organ-specific autoimmunity.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression is used to study the effects of increased gene dosage on organ-specific immunity. Overexpressing chemokines like CCL19 in a tissue can induce tertiary lymphoid structure formation. This approach helps identify drivers of local immune responses.
How EDITGENE Supports organ or tissue specific immune response Research
Researchers studying organ or tissue specific immune response-related genes often need to determine whether a candidate gene is causally involved in local immunity, and how its manipulation affects disease outcomes. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from knockout and point mutation to knock-in and overexpression models, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for organ or tissue specific immune response research.
Frequently Asked Questions About organ or tissue specific immune response
What is GO:0002251?
GO:0002251 is the Gene Ontology term for organ or tissue specific immune response, defined as an immune response taking place in an organ or tissues such as the liver, brain, mucosa, or nervous system.
What genes are involved in organ or tissue specific immune response?
Genes such as PAD4, ILC2, LTβR, CCL19, CCL21, and Foxp3 play key roles in local immune responses, including NET formation, type 2 immunity, and tertiary lymphoid structure formation [4,5,8].
Why is organ-specific immunity important?
It explains why immune responses differ between tissues and contributes to diseases like autoimmunity, chronic inflammation, and cancer [2,3].
What are tertiary lymphoid structures?
Tertiary lymphoid structures are organized aggregates of immune cells that form in non-lymphoid tissues during chronic inflammation, autoimmunity, and cancer.
How do structural cells regulate organ-specific immune responses?
Structural cells such as epithelial, endothelial, and stromal cells secrete cytokines and chemokines, present antigens, and organize immune cell recruitment and positioning [2,8].
What methods are used to study organ or tissue specific immune responses?
Common methods include single-cell RNA-seq, spatial transcriptomics, multiplex imaging, organoid cultures, and conditional knockout mouse models [2,5,6].
Can CRISPR be used to study organ-specific immunity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in tissue-specific immune responses [4,5,8].
What diseases involve dysregulated organ-specific immune responses?
Diseases include autoimmune conditions like rheumatoid arthritis and Sjögren's syndrome, sterile inflammatory liver injury, inflammatory bowel disease, and cancer [3,4,5].
How does the microbiota influence organ-specific immunity?
Microbiota-derived metabolites and signals shape immune cell development and function in organs such as the intestine and spleen [5,6].
What is the role of sex differences in organ-specific immunity?
Sex differences affect immune cell composition and function in a tissue-specific manner, influencing disease susceptibility and outcomes.
Conclusion
GO:0002251 organ or tissue specific immune response is a fundamental concept that captures the unique immune activities occurring within different organs and tissues. It involves complex interactions between resident immune cells, recruited leukocytes, and structural cells, and is regulated by local signals, microbiota, and systemic factors [2,5,6]. Dysregulation of these responses contributes to a wide range of diseases, from autoimmunity to cancer [3,4,8]. Advances in single-cell and spatial technologies, combined with CRISPR-based models, are enabling researchers to dissect the mechanisms of organ-specific immunity with unprecedented resolution [2,6]. EDITGENE provides the tools and services to support these discoveries, helping to translate basic findings into targeted therapies.
References
- 1. Mitul MT et al.. 2024. Tissue-specific sex differences in pediatric and adult immune cell composition and function.. Front Immunol 15:1373537 PMID: 38812520
- 2. Krausgruber T et al.. 2020. Structural cells are key regulators of organ-specific immune responses.. Nature 583(7815):296-302 PMID: 32612232
- 3. Guillaume SM et al.. 2025. Tertiary Lymphoid Structures Across Organs: Context, Composition, and Clinical Levers.. Immunol Rev 335(1):e70063 PMID: 40996881
- 4. Huang H et al.. 2015. Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury.. Hepatology 62(2):600-14 PMID: 25855125
- 5. Nadjsombati MS et al.. 2018. Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit.. Immunity 49(1):33-41.e7 PMID: 30021144
- 6. Zhang Y et al.. 2023. Microbiota-mediated shaping of mouse spleen structure and immune function characterized by scRNA-seq and Stereo-seq.. J Genet Genomics 50(9):688-701 PMID: 37156441
- 7. Bulgaru CV et al.. 2021. Zearalenone and the Immune Response.. Toxins (Basel) 13(4) PMID: 33807171
- 8. Asam S et al.. 2021. Stromal cells in tertiary lymphoid structures: Architects of autoimmunity.. Immunol Rev 302(1):184-195 PMID: 34060101
